Evaluation of the Emotional Burden of the Nurse (EMOCARE)

March 12, 2025 updated by: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Evaluation of the Emotional Burden of the Nurse in Onco-hematology

Asses the emotional burden on nursing staff and how much they are at risk for burnout.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The study involves the administration of a questionnaire paper questionnaire (maslach burnout scale) in the presence.

Study Type

Observational

Enrollment (Estimated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Nurse attached to uoc 1E hematology and TCSE and uoc 5E geriatric hematology and rare diseases.

Description

Inclusion Criteria:

  • Nursing personnel afferent to the OU of hematology and stem cell transplantation hematopoietic and the uoc geriatric hematology and rare hemapathies with more than 2 years of experience in the above departments.
  • Signature of informed consent.
  • Ability to understand and complete.

Exclusion Criteria:

  • Nursing staff not belonging to the departments of hematology
  • Failure to sign informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of emotional burden on nursing staff
Time Frame: 1 month
Maslach burnout scale
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Investigators

  • Principal Investigator: Fabio Lamberti, FPG

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2025

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

April 1, 2025

Study Registration Dates

First Submitted

March 12, 2025

First Submitted That Met QC Criteria

March 12, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 12, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 7360

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burnout, Professional

Clinical Trials on Maslach burnout inventory

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe